Showing results (1081-1090 of 1,802) with videos related to

Sort By:
Pageof 181
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2003
Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunctionElizabeth M Powell, Daniel B Campbell, Gregg D Stanwood, et al.
Genes|October 1, 2016
Impact of the Autism-Associated Long Noncoding RNA MSNP1AS on Neuronal Architecture and Gene Expression in Human Neural Progenitor CellsJessica J DeWitt, Nicole Grepo, Brent Wilkinson, et al.
The Journal of Clinical Investigation|December 1, 1979
Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitorsW B Campbell, C E Gomez-Sanchez, B V Adams, et al.
The British Journal of Surgery|January 25, 2006
Cost-effectiveness analysis of surgery versus conservative treatment for uncomplicated varicose veins in a randomized clinical trialJ Ratcliffe, J E Brazier, W B Campbell, et al.
Physical Review Letters|February 28, 2002
Surface charging and impulsive ion ejection during ultrashort pulsed laser ablationR Stoian, A Rosenfeld, D Ashkenasi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Gender differences in AIDS-associated Kaposi sarcoma in Harare, ZimbabweAmie L Meditz, Margaret Borok, Samantha MaWhinney, et al.
Journal of Palliative Medicine|June 15, 2012
HIV, aging, and advance care planning: are we successfully planning for the future?Kristine M Erlandson, Amanda A Allshouse, Syki Duong, et al.
Endocrinology|November 1, 2017
Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical ArteriesPhillip G Kopf, Sang-Kyu Park, Anja Herrnreiter, et al.
Journal of Orthopaedics|June 9, 2025
The risk analysis index as a predictor of 30-day mortality for elderly obese patients undergoing elective total joint arthroplastyNithin Gupta, Jared Sasaki, Victor Koltenyuk, et al.
HIV Medicine|March 15, 2012
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interestP-M Girard, T B Campbell, B Grinsztejn, et al.
Pageof 181